期刊文献+

洛伐他汀预适应在大鼠急性缺血再灌注中的心肌保护作用 被引量:3

The study of myocardial protection and its mechanisms of lovastatin preconditioning in the ischemic and reperfused rat hearts
原文传递
导出
摘要 目的:探讨洛伐他汀预适应对大鼠心脏急性缺血再灌注中的心肌保护作用及其机制。方法:将 24只SD大鼠随机分为3组(每组均8只):模型对照组(C组); 洛伐他汀组( L组),胃管直接灌注洛伐他汀 15 mg·kg-1·d-12周;洛伐他汀复合L 硝基精氨酸甲酯(L NAME)组(N组),洛伐他汀直接灌胃 2 周同时腹腔注射L NAME 30 mg·kg-1·d-1;2周后建立体内急性缺血再灌注心脏模型,监测缺血再灌注前后血流动力学各项指标,同时观察各组血脂水平及其血浆中丙二醛(MDA) 、心肌组织内超氧化物歧化酶(SOD)变化情况。结果: L组和N组较C组心率明显变慢(P<0.01),缺血再灌注心律失常消失和再灌注时-dp/dtmax下降明显改善(P<0.05);同时各项血脂指标不变,洛伐他汀能明显减少再灌注时血浆中MDA生成, 并且提高心肌组织SOD活性(P<0.05)。结论:洛伐他汀预适应对体内大鼠心脏急性缺血再灌注时具有非降脂外的心肌保护作用,其机制除与其增加一氧化氮(NO)合成相关外,可能还有其他物质或途径参与。 Objective:To investigate the protective effect of lovastatin on the ischemic and reperfused rat myocardium and its mechanism. Method:Twenty-four Sprague-Dawley male rats were randomly and evenly divided into three groups: model control group; Lovastatin group treated with 15 mg lovastatin per a kilogram once a day; L-NAME group treated with the same dose of lovastatin with lovastatin group and L-NAME 30 mg per a kilogram once a day. Rat models of I/R were established with coronary occlusion 30 mintues and reperfusion 30 mintues of the left anterior descending artery after two-week's administration. Hemodynamics was monitored during the period of ischemia and reperfusion. Superoside dismutase of myocardial tissue and malondialdehyde in blood serum were measured as well as lipin in blood serum. Result: In comparison with model control group, heart rate was reduced markedly and reperfused arrhythmia disappeared in the L group and N group.The descent of -dp/dt in the reperfused period was improved in both L and N group. Without lipin in the blood serum changed, Lovastatin decreased the yield of malondialdehyde(MDA) in the blood serum and rise the activity of superoside dismutase (SOD)in the myocardial tissue after ischemia and reperfusion.Conclusion: Lovastatin may have the protective effect on the ischemic and reperfused rat myocardium,but such effects didn't correclate to its effect on lipin in blood serum.There may have another something or pathway which correclate to its effect as well as NO synthesis increasing.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2005年第3期173-175,共3页 Journal of Clinical Cardiology
关键词 洛伐他汀 血流动力学 心肌保护 心肌再灌注损伤 Lovastatin Hemodynamics Myocardial protection Myocardial reperfusion injury
  • 相关文献

参考文献6

  • 1李小鹰,郑华光,刘玲玲,田亚平,赵亚力.腺苷A_1受体激动剂对兔心肌缺血-再灌注一氧化氮及其合酶基因表达的影响[J].中华心血管病杂志,1996,24(2):139-142. 被引量:13
  • 2Permpikul C, Eppinger M J.Pretreatment with statins enhances myocardial protection during coronary revascularizartion. J Thorac Cardiovasc Surg, 2003,125:1037-1042.
  • 3de Jong E R,de Jong J W. Ischemic preconditioning and glucose metabolism during low flow ischemia:role of the adenosine A1 receptor. Cardiovasc Res,1999,43:909 -918.
  • 4Liu G S,Thomton J,Winkle D M V.Protection against infarction afforded by preconditioning is mediatd by A1 adenosine receptors in rabbit heart. Circulation,1991,84:350-350.
  • 5Light P E. Cardiac K+-ATP channels and ischemic preconditioning:current perspectives. Can J Cardiol,1999,15:1123-1130.
  • 6王建春,王曙霞,邵建华.一氧化氮与心肌缺血预适应[J].心血管病学进展,2003,24(4):291-293. 被引量:5

二级参考文献6

共引文献16

同被引文献29

  • 1曾春,马中富,赵锋,梁艳冰,詹红,唐皓,熊艳,叶海宁.白细胞介素-18含量变化与急性心肌梗死的炎症关系[J].中国中西医结合急救杂志,2004,11(5):311-313. 被引量:16
  • 2戴淑华,蒋学俊,李建军.氟伐他汀对正常血脂兔心肌缺血再灌注损伤的保护作用[J].中国动脉硬化杂志,2005,13(2):183-185. 被引量:8
  • 3Lazar HL,Bao Y,Zhang Y,et al.Pretreatment with statins enhances myocardial protection during coronary revascularization[J].J Thorac Cardiovasc Surg,2003,125(5):1037-1042.
  • 4Ikeda Y,Young LH,Lefer AM.Rosuvastatin a new HMG-CoA reductase inhibitor,protects ischemic reperfused myocardium in normocholesterolemic rats[J].J Cardiovasc Pharmacol,2003,41(4):649-656.
  • 5Lefer AM,Campbell B,Shin YK,et al.Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts[J].Circulation,1999,100(2):178-184.
  • 6Weinberg EO,Scherrer-Crosbie M,Picard MH,et al.Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion[J].Am J Physiol Heart Circ Physiol,2005,288(4):H1802-H1809.
  • 7Birnbaum Y,Ashitkov T,Uretsky BF,et al.Reduction of infarct size by short-term pretreatment with atorvastatin[J].Cardiovasc Drugs Ther,2003,17(1):25-30.
  • 8Bell RM,Yellon DM.Atorvastatin,administered at the onset of reperfusion,and independent of lipid lowering,protects the myocardium by up-regulating a pro-survival pathway[J].J Am Coll Cardiol,2003,41(3):508-515.
  • 9Chen J,Nagasawa Y,Zhu BM,et al.Pravastatin prevents arrhythmias induced by coronary artery ischemia/reperfusion in anesthetized normocholesterolemic rats[J].J Pharmacol Sci,2003,93(1):87-94.
  • 10Marin F,Pascual DA,Roldan V,et al.Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting[J].Am J Cardiol,2006,97(1):55-60.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部